Construct · 1 fields · 1 citations

immunogenicity risk assessment: a standalone construct

One name. One construct. A landmark on the map.

● anchor · a standalone construct Nearest construct by meaning·not indexed
immunogenicityrisk assessment1 CONSTRUCTImmunogenicity riskSHANKAR · BIOPHARMACEUTICAL

A single standalone construct; nearby constructs are located against it in the Collider. Tap a field for its definition, unit, and measures.

Biopharmaceutical development

structured weighing of product and patient factors that could lead to antibodies against a protein drug.

In biopharmaceutical development, immunogenicity risk assessment refers to structured weighing of product and patient factors that could lead to antibodies against a protein drug. This meaning comes from Shankar (2006) in Trends in Biotechnology.[1]

Unit
Recovery means
Measured by

Next

Run it through the Collider, or take the citations with you.

See how immunogenicity risk assessment sits against neighbouring constructs in the Collider, or export every reference on this page in one click.

Open in ColliderExport BibTeXReport this entry

Nearby constructs

development1 fields · 2 citationsanchor · a standalone constructproduct3 fields · 3 citationsjingle · one word, three constructsrisk6 fields · 13 citationsjingle · one name, six constructs

References

  1. Shankar, G., Shores, E., Wagner, C., & Mire-Sluis, A. (2006). Scientific and regulatory considerations on the immunogenicity of biologics. Trends in Biotechnology, 24(6), 274-280. https://doi.org/10.1016/j.tibtech.2006.04.001

Cited on this page?

Confirm your construct, or correct us.

If your work is cited behind one of these entries, you know better than we do whether we captured the meaning right. Confirm it, suggest an edit, or dispute it, and your name goes on the entry as an author who has checked it, linked to your ORCID.

Claim your construct